Skip to content

Investment Resources

  • Blog

Biotech Breakouts | May 18th FDA Insider Watch List

May 24, 2018May 18, 2018 by John Gladston

Table of Contents

  • 1 UPDATE: To Watch the Replay of Kyle’s Option Rocket Webinar
  • 2 >>> Click Here and Register <<<
  • 3 Related

UPDATE: To Watch the Replay of Kyle’s Option Rocket Webinar

>>> Click Here and Register <<<

You’ll receive your replay link in a few minutes.

Big Alert: I’m having an exclusive webinar on May 24th at 8 PM Eastern. I’ll be releasing a new option strategy I’m calling I.G.N.I.T.E. I’ll also be showing how you can use a simple option strategy to hit huge percentage returns in all types of stocks.

I already have thousands of people attending and our servers can only hold so many, so be sure to secure your seat right now!

Really nice day out there again! The best trade of the day ended up being one of our quick moving opportunities. VTVT was about $5,000 in profits!

I also picked up a position again in IDRA. The data from their abstract at ASCOlooked promising, and the company also has another data release coming in June. A two for one special!

I took a started position in GBT as well, right from our watch list.

So was quite the busy day.

Just a reminder, charts and targets are updated every Monday morning!


—– Related —–

FREE DOWNLOAD
Kyle Dennis FREE EBOOK “The $2.9 Million Biotech Trader Playbook”

This book has helped thousands of other traders learn the basics of biotech, and how to easily spot winning trades.

Whether you are new trader or a 30-year veteran, this book will help you find stocks that are primed to make parabolic moves. These strategies are Kyle’s secret weapons that have help him net over $3 Million in profits…and they are all yours for free.

This is normally $97.00, but it’s yours FREE!


 

New Catalyst Swing names (1 – 4 week holds) I am watching…

 

Idera Pharmaceuticals (IDRA)

 

Catalyst Dates: Phase 2 data due out June 4th and another Phase 2 data readout in June

 

Buy Zone: $1.75 to $1.95

Profit Zone: $2.20 or higher

Stop Zone: $1.70 or below

 

 

Catalyst Swing names (1 – 4 week holds) I am watching…

 

Aquinox Pharmaceuticals (AQXP)

Catalyst Dates: Phase 3 data due out in the third quarter

 

Buy Zone: $12.50 to $13.50

Profit Zone: $16.00 or higher

Stop Zone: $11.50 or below

 

 

Bellerophon Therapeutics (BLPH)

Catalyst Dates: Interim Phase 3 data release in the middle of 2018 (likely late June or July)

 

Buy Zone: $2.20 to $2.40

Profit Zone: $2.75 or higher

Stop Zone: $2.10 or below

 

 

Durect Corporation (DRRX)

Catalyst Dates: Advisory Committee meeting on June 26th, FDA Approval dates on July 28th and August 7th.

 

Buy Zone: $1.75 to $2.00

Profit Zone: $2.40 or higher

Stop Zone: $1.65 or below

 

 

Array BioPharma (ARRY)

Catalyst Dates: Phase 3 data due out June 20-23. FDA approval date of June 30 as well.

 

Buy Zone: $14.50 to $15.50

Profit Zone: $18.00 or higher

Stop Zone: $14.00 or below

 

 

Global Blood Therapeutics (GBT)

Catalyst Dates: Phase 3 data likely due out in June. Officially in the “first half”

 

Buy Zone: $48.00 to $50.00

Profit Zone: $57.00 or higher

Stop Zone: $45.00 or below

 

 

Pluristem Therapeutics (PSTI)

Catalyst Dates: Phase 2 data due out to be published in June.

 

Buy Zone: $1.30 to $1.45

Profit Zone: $1.80 or higher

Stop Zone: $1.20 or below

 

 

Marinus Pharmaceuticals (MRNS)

Catalyst Dates: Phase 2 data due out in the third quarter. Two other Phase 2 datas due out in the fourth quarter.

 

Buy Zone: $4.25 to $4.75

Profit Zone: $6.00 or higher

Stop Zone: $4.00 or below

 

 

Cytokinetics Incorporated (CYTK)

Catalyst Dates: Phase 2 data due out June 16

 

Buy Zone: $8.50 to $9.00

Profit Zone: $10.00 or higher

Stop Zone: $7.40 or below

 

 

Zogenix (ZGNX)

Catalyst Dates: Phase 3 data due late second quarter (likely June)

 

Buy Zone: $39.50 to $40.50

Profit Zone: $45.00 or higher

Stop Zone: $37.50 or below

 

 

Catalyst Biosciences (CBIO)

Catalyst Dates: Phase 2 data in July

 

Buy Zone: $26.50 to $28.50

Profit Zone: $33.00 or higher

Stop Zone: $25.00 or below

 

 

Pain Therapeutics (PTIE)

Catalyst Dates: Advisory Committee Meeting June 26th and FDA approval date of August 7th

 

Buy Zone: $7.50 to $8.25

Profit Zone: $9.50 or higher

Stop Zone: $7.00 or below

 

 


[Ed.note: Kyle Dennis runs BiotechBreakouts.com. He is an event-based trader, who prefers low-priced and small-cap biotech stocks.

To learn more JOIN THIS SPECIAL ONLINE EVENT: 3-Step Plan Kyle Used to Turn $15,253 into $2,855,475 and download his FREE “The $2.9 Million Biotech Trader Playbook here!]

Related

Categories Kyle Dennis Biotech Breakouts Tags Biotech Breakouts, biotech breakouts kyle dennis review, biotech breakouts login, Biotech Breakouts Review, Biotech Breakouts reviews, Biotech Breakouts scam, Biotech Breakouts Stock Alerts Service Review, Biotech Breakouts Stock Alerts Service Scam, Biotech Nucleus, Biotech Nucleus Cost, Biotech Nucleus Customer Review, Biotech Nucleus Good, Biotech Nucleus Kyle, Biotech Nucleus Kyle Dennis, Biotech Nucleus Legit, Biotech Nucleus Real Member Review, Biotech Nucleus Review, Biotech Nucleus Reviews, Biotech Nucleus Scam, Biotech Nucleus User experience, FDA Insider & Lightning Alerts, FDA Insider & Lightning Alerts Kyle Dennis, FDA Insider & Lightning Alerts Review, FDA Insider & Lightning Alerts Reviews, FDA Insider & Lightning Alerts Scam, FDA Insider Alert Free, FDA Insider Alert review, FDA Insider Alert reviews, FDA Insider Alert scam, fda insider alerts, I.G.N.I.T.E., I.G.N.I.T.E. Options Kyle Dennis, I.G.N.I.T.E. Options Strategy, I.G.N.I.T.E. Options Strategy Kyle Dennis, I.G.N.I.T.E. Review, kyle biotech breakouts, Kyle Dennis, Kyle Dennis FDA Insider & Lightning Alerts, Kyle Dennis FDA Insider & Lightning Alerts Review, Kyle Dennis FDA Insider & Lightning Alerts Scam, Kyle Dennis FDA Insider Alert review, Kyle Dennis fda insider alerts, Kyle Dennis fda insider alerts review, Kyle Dennis fda insider alerts scam, Kyle Dennis lightning alerts, Kyle Dennis lightning alerts review, Kyle Dennis lightning alerts scam, Kyle Dennis review, Kyle Dennis scam, Kyle Dennis Stocks, Kyle Dennis Stocks review, Kyle Dennis Stocks scam, Lightning Alerts Free, Lightning Alerts Review, Lightning Alerts Reviews, Lightning Alerts Scam, Middle-Class Millionaire Kyle Dennis, Middle-Class Millionaire: From $80K in Debt to $3M in Profits through Catalyst Trading, Option Rocket Kyle Dennis, Option Rocket Review, Option Rocket Reviews, Option Rocket Scam, Options Rocket Kyle Dennis, Options Rocket login, Options Rocket Review, Options Rocket Reviews, Options Rocket Scam, Options Rocket User experience, Options Rocket user review, Options Rocket webinar, Options Rocket website
Dynamic Profit Targets Live Strategy Class with John Carter
Kyle Dennis Options Rocket Strategy | 1476% returns in 7 months…VERIFIED

Marc Chaikin Prediction - Top Stocks to Buy in 2024

Marc Chaikin Prediction

Join our list

2023 Wealth Protection Kit

Investment in Gold or Silver

“Get The FREE 2023 Wealth Protection Kit Americans Are Using To Protect Their Retirement Savings” – Sean Hannity

Click Here to Request Your Free Guide

Top 7 Trading Resources

Best Trading Advice

Steady Income Investments

Crypto News

Options Trading Strategies

Top Marijuana Stocks

FREE Trade Alerts

Best Blockchain Stocks to Buy

© 2023 Investment Resources • Built with GeneratePress